BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3069 related articles for article (PubMed ID: 30820047)

  • 41. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
    Wightman DP; Jansen IE; Savage JE; Shadrin AA; Bahrami S; Holland D; Rongve A; Børte S; Winsvold BS; Drange OK; Martinsen AE; Skogholt AH; Willer C; Bråthen G; Bosnes I; Nielsen JB; Fritsche LG; Thomas LF; Pedersen LM; Gabrielsen ME; Johnsen MB; Meisingset TW; Zhou W; Proitsi P; Hodges A; Dobson R; Velayudhan L; Heilbron K; Auton A; ; Sealock JM; Davis LK; Pedersen NL; Reynolds CA; Karlsson IK; Magnusson S; Stefansson H; Thordardottir S; Jonsson PV; Snaedal J; Zettergren A; Skoog I; Kern S; Waern M; Zetterberg H; Blennow K; Stordal E; Hveem K; Zwart JA; Athanasiu L; Selnes P; Saltvedt I; Sando SB; Ulstein I; Djurovic S; Fladby T; Aarsland D; Selbæk G; Ripke S; Stefansson K; Andreassen OA; Posthuma D
    Nat Genet; 2021 Sep; 53(9):1276-1282. PubMed ID: 34493870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multi-center study of ACE and the risk of late-onset Alzheimer's disease.
    Belbin O; Brown K; Shi H; Medway C; Abraham R; Passmore P; Mann D; Smith AD; Holmes C; McGuinness B; Craig D; Warden D; Heun R; Kölsch H; Love S; Kalsheker N; Williams J; Owen MJ; Carrasquillo M; Younkin S; Morgan K; Kehoe PG
    J Alzheimers Dis; 2011; 24(3):587-97. PubMed ID: 21297258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
    Cruchaga C; Kauwe JS; Harari O; Jin SC; Cai Y; Karch CM; Benitez BA; Jeng AT; Skorupa T; Carrell D; Bertelsen S; Bailey M; McKean D; Shulman JM; De Jager PL; Chibnik L; Bennett DA; Arnold SE; Harold D; Sims R; Gerrish A; Williams J; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Peskind ER; Galasko D; Fagan AM; Holtzman DM; Morris JC; ; ; ; Goate AM
    Neuron; 2013 Apr; 78(2):256-68. PubMed ID: 23562540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
    Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
    J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
    Femminella GD; Harold D; Scott J; Williams J; Edison P;
    J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.
    Picard C; Julien C; Frappier J; Miron J; Théroux L; Dea D; ; Breitner JCS; Poirier J
    Neurobiol Aging; 2018 Jun; 66():180.e1-180.e9. PubMed ID: 29503034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetics of Alzheimer's disease.
    Chouraki V; Seshadri S
    Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
    Katzov H; Chalmers K; Palmgren J; Andreasen N; Johansson B; Cairns NJ; Gatz M; Wilcock GK; Love S; Pedersen NL; Brookes AJ; Blennow K; Kehoe PG; Prince JA
    Hum Mutat; 2004 Apr; 23(4):358-67. PubMed ID: 15024730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of common and rare APP DNA sequence variants in Alzheimer disease.
    Hooli BV; Mohapatra G; Mattheisen M; Parrado AR; Roehr JT; Shen Y; Gusella JF; Moir R; Saunders AJ; Lange C; Tanzi RE; Bertram L
    Neurology; 2012 Apr; 78(16):1250-7. PubMed ID: 22491860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
    Jun G; Asai H; Zeldich E; Drapeau E; Chen C; Chung J; Park JH; Kim S; Haroutunian V; Foroud T; Kuwano R; Haines JL; Pericak-Vance MA; Schellenberg GD; Lunetta KL; Kim JW; Buxbaum JD; Mayeux R; Ikezu T; Abraham CR; Farrer LA
    Ann Neurol; 2014 Sep; 76(3):379-92. PubMed ID: 25043464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.
    Li Y; Laws SM; Miles LA; Wiley JS; Huang X; Masters CL; Gu BJ
    Cell Mol Life Sci; 2021 Dec; 78(23):7397-7426. PubMed ID: 34708251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    Darst BF; Koscik RL; Racine AM; Oh JM; Krause RA; Carlsson CM; Zetterberg H; Blennow K; Christian BT; Bendlin BB; Okonkwo OC; Hogan KJ; Hermann BP; Sager MA; Asthana S; Johnson SC; Engelman CD
    J Alzheimers Dis; 2017; 55(2):473-484. PubMed ID: 27662287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity.
    Yang M; Zinkgraf M; Fitzgerald-Cook C; Harrison BR; Putzier A; Promislow DEL; Wang AM
    G3 (Bethesda); 2023 Aug; 13(9):. PubMed ID: 37311212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
    Moreno-Grau S; de Rojas I; Hernández I; Quintela I; Montrreal L; Alegret M; Hernández-Olasagarre B; Madrid L; González-Perez A; Maroñas O; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Abdelnour C; Rodríguez-Gómez O; Gil S; Santos-Santos MÁ; Espinosa A; Ortega G; Sanabria Á; Pérez-Cordón A; Cañabate P; Moreno M; Preckler S; Ruiz S; Aguilera N; Pineda JA; Macías J; Alarcón-Martín E; Sotolongo-Grau O; ; ; ; Marquié M; Monté-Rubio G; Valero S; Benaque A; Clarimón J; Bullido MJ; García-Ribas G; Pástor P; Sánchez-Juan P; Álvarez V; Piñol-Ripoll G; García-Alberca JM; Royo JL; Franco E; Mir P; Calero M; Medina M; Rábano A; Ávila J; Antúnez C; Real LM; Orellana A; Carracedo Á; Sáez ME; Tárraga L; Boada M; Ruiz A
    Alzheimers Dement; 2019 Oct; 15(10):1333-1347. PubMed ID: 31473137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.
    Sepulcre J; Grothe MJ; d'Oleire Uquillas F; Ortiz-Terán L; Diez I; Yang HS; Jacobs HIL; Hanseeuw BJ; Li Q; El-Fakhri G; Sperling RA; Johnson KA
    Nat Med; 2018 Dec; 24(12):1910-1918. PubMed ID: 30374196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 154.